Syncardia TAH
This article was originally published in The Gray Sheet
Executive Summary
Syncardia takes step toward more mobile CardioWest Total Artificial Heart through license of small, lightweight driver from MEDOS medizintechnik AG in Stolberg, Germany, announced Sept. 8. Syncardia currently is planning an IDE for a more portable TAH to follow PMA approval of the first-generation device - expected later this year - and has discussed development of a TAH that fits in a backpack (1"The Gray Sheet" Feb. 23, 2004, p. 20)...
You may also be interested in...
SynCardia Plans U.S. Equivalency Trial Of Portable Total Artificial Heart
SynCardia's CardioWest Total Artificial Heart could be used in up to 500 U.S. cardiac transplant candidates annually, according to the firm
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.